Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Barata, Fernando [1 ]
Sousa, Amelia [2 ]
Camacho, Elvira [3 ]
Costa, Marco S. [4 ]
Canario, Dolores [5 ]
Nogueira, Fernando [6 ]
Semedo, Eulalia [7 ]
机构：
[1] Ctr Hosp Coimbra, Unidade Pneumol, Coimbra, Portugal
[2] Hosp Univ Coimbra, Serv Pneumol, Coimbra, Portugal
[3] Hosp Nossa Senhora do Rosario, Serv Pneumol, Barreiro, Portugal
[4] Hosp Dist Santarem, Serv Pneumol, Santarem, Portugal
[5] Hosp Garcia Dorta, Serv Pneumol, Almada, Portugal
[6] Hosp Egas Moniz, Serv Pneumol, Lisbon, Portugal
[7] Hosp S Bernardo, Serv Pneumol, Setubal, Portugal
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [1] Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer
    Barata, F
    Camacho, E
    Sousa, A
    Costa, MS
    Resende, R
    Meleiro, A
    Nogueira, F
    Pereira, A
    Canário, D
    [J]. LUNG CANCER, 2005, 49 : S235 - S235
  • [2] Gemcitabine/platinum alone or in combination with cetuximab as first-line treatment for advanced non-small cell lung cancer (NSCLC)
    Butts, C. A.
    Bodkin, D.
    Middleman, E. L.
    Englund, C. W.
    Ellison, D.
    Alam, Y. Z.
    Pautret, V.
    Weber, M.
    Kreisman, H.
    Shepherd, F. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Fleeman, N.
    Bagust, A.
    McLeod, C.
    Greenhalgh, J.
    Boland, A.
    Dundar, Y.
    Dickson, R.
    Smith, C. Tudur
    Davis, H.
    Green, J.
    Pearson, M.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53
  • [4] Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Brown, T.
    Boland, A.
    Bagust, A.
    Oyee, J.
    Hockenhull, J.
    Dundar, Y.
    Dickson, R.
    Ramani, V. S.
    Proudlove, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 71 - 79
  • [5] Phase I study of docetaxel in combination with Gemcitabine as first line chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Gatzemeier, U
    Bildat, S
    Harstrick, A
    Eberhardt, W
    Achterrath, W
    Krauss, C
    Wilke, HJ
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 93 - 93
  • [6] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Dane, Faysal
    Isikdogan, Abdurrahman
    Ustaalioglu, Basak Oven
    Coskun, Ugur
    Yumuk, Perran Fulden
    Dogu, Gamze Gokoz
    Ozdemir, Nuriye Yildirim
    Sevinc, Alper
    Gumus, Mahmut
    Ozkan, Metin
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    [J]. TUMORI JOURNAL, 2010, 96 (03): : 400 - 404
  • [7] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    [J]. ONKOLOGIE, 2003, 26 : 26 - 32
  • [9] Combination of docetaxel (DTX) and gemcitabine (G) in patients with inoperable or metastatic non-small cell lung cancer (NSCLC). A phase I study
    Rebattu, P
    Pujol, JL
    Ardiet, C
    Quentin, X
    Droz, JP
    Dumortier, A
    Khial, F
    Schuller, MP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 95 - 95
  • [10] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
12345